Deutsche Bank Ag\ Ngm Biopharmaceuticals Inc Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $127,766 - $278,956	212,944 New	212,944 $183,000
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $16,101 - $29,893	-6,599 Reduced 2.77%	231,917 $600,000
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $19,861 - $28,830	-5,339 Reduced 2.19%	238,516 $973,000
Q4 2022 Feb 13, 2023	SELL	$3.41 - $12.93 $64,776 - $245,618	-18,996 Reduced 7.23%	243,855 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $13,357 - $18,747	-1,061 Reduced 0.4%	262,851 $3.44 Million
Q2 2022 Aug 11, 2022	BUY	$10.58 - $17.5 $973,550 - $1.61 Million	92,018 Added 53.53%	263,912 $3.38 Million
Q1 2022 May 13, 2022	BUY	$13.81 - $18.6 $50,406 - $67,890	3,650 Added 2.17%	171,894 $2.62 Million
Q4 2021 Feb 11, 2022	SELL	$17.26 - $22.02 $137,924 - $175,961	-7,991 Reduced 4.53%	168,244 $2.98 Million
Q3 2021 Nov 04, 2021	BUY	$20.15 - $26.19 $471,127 - $612,348	23,381 Added 15.3%	176,235 $3.71 Million
Q2 2021 Aug 11, 2021	SELL	$15.06 - $30.03 $1.68 Million - $3.36 Million	-111,848 Reduced 42.25%	152,854 $3.01 Million
Q1 2021 May 13, 2021	BUY	$24.99 - $31.93 $6.17 Million - $7.88 Million	246,926 Added 1389.1%	264,702 $7.69 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $77,581 - $150,471	4,786 Added 36.84%	17,776 $539,000
Q3 2020 Nov 12, 2020	BUY	$15.59 - $19.97 $17,710 - $22,685	1,136 Added 9.58%	12,990 $207,000
Q2 2020 Aug 13, 2020	BUY	$11.97 - $23.47 $24,622 - $48,277	2,057 Added 21.0%	11,854 $234,000
Q1 2020 May 14, 2020	BUY	$10.0 - $19.51 $8,190 - $15,978	819 Added 9.12%	9,797 $121,000
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $69,341 - $141,047	6,955 Added 343.8%	8,978 $165,000
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $17,880 - $24,847	-1,366 Reduced 40.31%	2,023 $26,000
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $42,565 - $56,257	3,389 New	3,389 $49,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account